SCHEMBL23031885

SCHEMBL23031885

N=C/C(COCc1ccc(/C(N)=N/N=C\N)cc1)=N\NCCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23032002 0.79 AGER (0.36) —
SCHEMBL23032003 0.78 ALDH1A1 (0.32) —
SCHEMBL23031884 0.77 RAB9A (0.35) —
SCHEMBL23031880 0.76 ALDH1A1 (0.35) —
SCHEMBL23031883 0.75 KDM4E (0.31) —
SCHEMBL23031852 0.73 ALDH1A1 (0.32) —
SCHEMBL23031869 0.71 PARP1 (0.36) —
SCHEMBL21300883 0.67 LOXL2 (0.47) —
SCHEMBL23031878 0.62 LMNA (0.44) —
SCHEMBL22815269 0.62 KDM1A (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021034924-A1 TRANS-CYCLOOCTENE LABELED ANTISENSE OLIGONUCLEOTIDES, RADIO LABELED TETRAZINE AND METHODS BIOGEN MA INC. (US) 2021-02-25 — — WO disclosed
Send feedback